Visual impairment and medication safety: a protocol for a scoping review.
Medication safety
Visual impairment
Journal
Systematic reviews
ISSN: 2046-4053
Titre abrégé: Syst Rev
Pays: England
ID NLM: 101580575
Informations de publication
Date de publication:
15 09 2021
15 09 2021
Historique:
received:
26
10
2020
accepted:
25
08
2021
entrez:
16
9
2021
pubmed:
17
9
2021
medline:
27
10
2021
Statut:
epublish
Résumé
The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people. Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics. The review will summarise the literature relating to medication safety and visual impairment.
Sections du résumé
BACKGROUND
The number of individuals with a visual impairment in the UK was estimated a few years ago to be around 1.8 million. People can be visually impaired from birth, childhood, early adulthood or later in life. Those with visual impairment are subject to health inequities and increased risk for patient safety incidents in comparison to the general population. They are also known to be at an increased risk of experiencing medication errors compared to those without visual impairment. In view of this, this review aims to understand the issues of medication safety for VI people.
METHODS/DESIGN
Four electronic bibliographic databases will be searched: MEDLINE, Embase, PsycInfo and CINAHL. Our search strategy will include search combinations of two key blocks of terms. Studies will not be excluded based on design. Included studies will be empirical studies. They will include studies that relate to both medication safety and visual impairment. Two reviewers (SG and LR) will screen all the titles and abstracts. SG, LR, RM, SCS and PL will perform study selection and data extraction using standard forms. Disagreements will be resolved through discussion or third party adjudication. Data to be collected will include study characteristics (year, objective, research method, setting, country), participant characteristics (number, age, gender, diagnoses), medication safety incident type and characteristics.
DISCUSSION
The review will summarise the literature relating to medication safety and visual impairment.
Identifiants
pubmed: 34526103
doi: 10.1186/s13643-021-01800-8
pii: 10.1186/s13643-021-01800-8
pmc: PMC8442271
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
248Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2021. The Author(s).
Références
Inform Health Soc Care. 2019 Jan;44(1):70-78
pubmed: 29035664
Clin Nurse Spec. 2010 May-Jun;24(3):149-53
pubmed: 20404623
Cochrane Database Syst Rev. 2015 Mar 10;(3):CD006208
pubmed: 25756542
BMC Health Serv Res. 2018 Jan 30;18(1):63
pubmed: 29382329
BMJ. 2012 Jan 30;344:e542
pubmed: 22290101
Int J Clin Pharm. 2019 Dec;41(6):1400-1407
pubmed: 31531815
Br J Ophthalmol. 2012 May;96(5):614-8
pubmed: 22133988
Ophthalmologe. 2012 Jan;109(1):21-9
pubmed: 22274294
Chronic Illn. 2015 Jun;11(2):77-92
pubmed: 24920009
Disabil Rehabil. 2010;32(4):317-25
pubmed: 20055570